ISRCTN21164124已完成不适用

A pilot randomized placebo-controlled trial of coenzyme Q10 in fibromyalgia patients

Andalusian Federation of Fibromyalgia and Chronic Fatigue Syndrome (Spain)0 个研究点目标入组 20 人开始时间: 2012年9月12日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Male and female patients between 18 and 65 years old
•2. Has FM according to official diagnostic criteria for FM established in 1990 by the American College of Rheumatology (ACR)
•3. Duration of the illness of ten years or less

•1. History of renal failure (creatinine equal to or superior than 1.8 mL/dL), coronary disease in the last six months, angina, congestive heart disease, diabetes mellitus type one and two
•2. Any life-threatening chronic disease (i.e., cancer disease, inflammatory bowel disease and active immune disorders)
•3. Rheumatic disease (i.e., inflammatory arthritis, polymyositis, polymyalgia rheumatica)
•4. Osteomalacia and osteoporosis
•5. Metabolic and endocrine disease (i.e., hypothyroidism and hyperthyroidism, hyperparathyroidism, adrenal insufficiency, metabolic myopathy)
•6. Infectious diseases (i.e., Epstein-Barr virus disease, brucellosis)
•7. Rheumatic disease of soft tissue and myofascial pain syndrome
•8. Parkinson?s disease
•9. Women to become pregnant or nursing
•10. Patients who are enrolled in other clinical trial or patients who participated in other clinical trial in the last 30 days
•11. Any psychological or psychiatric disease to compromise the understanding of the instructions giving by the investigator
•12. Any subject to be unable to follow a good complementation of the treatment
•13. Any patient who denies to give the informed consent to participate in this trial

发起方

Andalusian Federation of Fibromyalgia and Chronic Fatigue Syndrome (Spain)